Overview

Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the safety and efficacy of a topical lotion
Phase:
Phase 2
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Collaborator:
Dow Pharmaceutical Sciences